• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干重排烟曲霉素 ABBA 及其类似物的全合成及其对耐药性神经氨酸酶的潜在抑制活性。

Total synthesis of dryocrassin ABBA and its analogues with potential inhibitory activity against drug-resistant neuraminidases.

机构信息

State Key Laboratory of Phytochemistry and Plant Resources in West China, and Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, People' s Republic of China; University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.

The Fifth Department of Biological Products, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, People's Republic of China.

出版信息

Bioorg Med Chem. 2019 Sep 1;27(17):3846-3852. doi: 10.1016/j.bmc.2019.07.013. Epub 2019 Jul 8.

DOI:10.1016/j.bmc.2019.07.013
PMID:31324565
Abstract

The stems of Dryopteris crassirhizoma, one of the main components of Lianhua-Qingwen Formula (LQF) was traditionally used for heat-clearing and detoxifying. Dryocrassin ABBA is a key antiviral component in the herbal medicine while the compound is hard to get in large amounts with the features of homologous compounds, polyphenol groups, and low contents. Therefore, the present work aims to seek influenza H7N9 virus inhibitors from natural source by synthesis of dryocrassin ABBA and its analogues. As a result, total synthesis of the compound was achieved in nine steps with an over-all yield of 4.6%. Neuraminidases (NAs) inhibitory activities of the synthesized product and its analogues were evaluated afterward. Comparing with the positive control, OSV (9.6 μM), it was very exciting that dryocrassin ABBA and its analogues (b5 and e2) showed better NAs inhibitory activity against Anhui H7N9 with IC values of 3.6 μM, 2.5 μM and 1.6 μM. For the highly resistant Shanghai N9, these compounds can also show medium inhibitory activities. Docking results indicated the direct interaction of synthesized 3 hits with the key K294 by hydrogen bonds, but no direct interaction of OSV with the key K294 was observed in Shanghai N9. This study suggested that dryocrassin ABBA and its analogues especially AB, which consisted of polyphenol groups may have beneficial effects on treating avian influenza H7N9 virus.

摘要

贯众是连花清瘟配方(LQF)的主要成分之一,其根茎历来被用作清热解毒。蛇足石杉中的蛇足杉脂碱 ABBA 是该草药中的一种关键抗病毒成分,但由于其结构与同系物相似、含有多酚基团以及含量较低,因此难以大量获取。因此,本研究旨在通过合成蛇足杉脂碱 ABBA 及其类似物,从天然产物中寻找抗流感 H7N9 病毒的抑制剂。研究结果成功地以 9 步反应实现了化合物的全合成,总收率为 4.6%。随后对合成产物及其类似物的神经氨酸酶(NA)抑制活性进行了评估。与阳性对照物 OSV(9.6 μM)相比,令人非常兴奋的是,蛇足杉脂碱 ABBA 及其类似物(b5 和 e2)对安徽 H7N9 表现出更好的 NA 抑制活性,IC 值分别为 3.6 μM、2.5 μM 和 1.6 μM。对于高耐药性的上海 N9,这些化合物也表现出中等抑制活性。对接结果表明,3 个命中化合物通过氢键与关键的 K294 直接相互作用,而 OSV 与上海 N9 中的关键 K294 则没有直接相互作用。本研究表明,蛇足杉脂碱 ABBA 及其类似物,特别是含有多酚基团的 AB,可能对治疗禽流感 H7N9 病毒具有有益作用。

相似文献

1
Total synthesis of dryocrassin ABBA and its analogues with potential inhibitory activity against drug-resistant neuraminidases.干重排烟曲霉素 ABBA 及其类似物的全合成及其对耐药性神经氨酸酶的潜在抑制活性。
Bioorg Med Chem. 2019 Sep 1;27(17):3846-3852. doi: 10.1016/j.bmc.2019.07.013. Epub 2019 Jul 8.
2
Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma.粗茎鳞毛蕨根茎中间苯三酚类化合物的抗甲型流感病毒(H5N1)活性筛选
Molecules. 2017 Mar 8;22(3):431. doi: 10.3390/molecules22030431.
3
Synthesis and biological evaluation of NH-acyl oseltamivir analogues as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的NH-酰基奥司他韦类似物的合成及生物学评价
Eur J Med Chem. 2017 Dec 1;141:648-656. doi: 10.1016/j.ejmech.2017.10.004. Epub 2017 Oct 5.
4
Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses.鉴定两株人感染 H7N9 禽流感病毒的神经氨酸酶特性。
Cell Res. 2013 Dec;23(12):1347-55. doi: 10.1038/cr.2013.144. Epub 2013 Oct 29.
5
Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.神经氨酸酶抑制剂存在下连续传代选择的 A(H7N9) 流感病毒中神经氨酸酶的取代特征。
Antiviral Res. 2019 Aug;168:68-75. doi: 10.1016/j.antiviral.2019.05.009. Epub 2019 May 25.
6
Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of by Targeting the Main Protease of SARS-CoV-2.源自绵马根茎的天然间苯三酚类化合物地奥酚ABBA和绵马酸ABA通过靶向SARS-CoV-2主要蛋白酶的抗冠状病毒活性
Pharmaceutics. 2022 Feb 8;14(2):376. doi: 10.3390/pharmaceutics14020376.
7
Dryocrassin ABBA Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells Through a Caspase-Dependent Mitochondrial Pathway.绵马贯众素ABBA通过半胱天冬酶依赖性线粒体途径诱导人肝癌HepG2细胞凋亡。
Asian Pac J Cancer Prev. 2016;17(4):1823-8. doi: 10.7314/apjcp.2016.17.4.1823.
8
Application of a sensitive and accurate LC-MS/MS method for determination of dryocrassin ABBA in rat plasma for a bioavailability study.一种灵敏且准确的液相色谱-串联质谱法在大鼠血浆中测定干酪素ABBA用于生物利用度研究的应用。
Biomed Chromatogr. 2014 Sep;28(9):1205-11. doi: 10.1002/bmc.3147. Epub 2014 Feb 4.
9
Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.非人灵长类动物中出现对神经氨酸酶抑制剂耐药的H7N9甲型流感病毒
Antimicrob Agents Chemother. 2015 Aug;59(8):4962-73. doi: 10.1128/AAC.00793-15. Epub 2015 Jun 8.
10
Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.新型奥司他韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Dec 15;27(24):5429-5435. doi: 10.1016/j.bmcl.2017.11.003. Epub 2017 Nov 4.

引用本文的文献

1
Screening novel antiviral compounds to treat Clostridioides difficile infections.筛选新型抗病毒化合物以治疗艰难梭菌感染。
PLoS One. 2024 Dec 13;19(12):e0309624. doi: 10.1371/journal.pone.0309624. eCollection 2024.
2
Efficacy and safety of Lianhua Qingwen as an adjuvant treatment for influenza in Chinese patients: A meta-analysis.连花清瘟辅助治疗中国流感患者的疗效和安全性:一项荟萃分析。
Medicine (Baltimore). 2024 Jan 19;103(3):e36986. doi: 10.1097/MD.0000000000036986.